Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
17-OHPC for Prevention of Emergent Cesarean in Placenta Previa
NCT03779438Unknown
- Sponsor
- Aswan University Hospital
- Start
- Jan 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in placenta previa comparing 17-OHPC with Placebo (2 arms). Primary endpoint: Duration of prolongation of pregnancy at 6 weeks. Status: unknown.
02
Drugs
hydroxyprogesterone caproate
03
Conditions
placenta previa
Beyond the preview
Go deeper on NCT03779438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03779438.